4//SEC Filing
BIOSPECIFICS TECHNOLOGIES CORP 4
Accession 0001062993-14-006901
CIK 0000875622operating
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 4:27 PM ET
Size
4.8 KB
Accession
0001062993-14-006901
Insider Transaction Report
Form 4
Schamroth Michael
Director
Transactions
- Sale
Common Stock, $0.001 par value
2014-11-24$39.36/sh−4,499$177,063→ 30,000 total
Footnotes (1)
- [F1]The selling price of $39.3560 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $39.20 to $39.50. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875622
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 4:27 PM ET
- Size
- 4.8 KB